2Chobanian AV,B akris GL,B lack HR. Thes eventhre porto fth ejo intna tionalc ommittee o n p revention,d etection,evaluation,and treatment of high blood pressue[J].Journal of the American Medical Association,2003,(19):2560-2576.
2Palatini P, Julius S. Pathophysiology of the association between increased heart rate and cardiovascular morbidity and mortality. Medicographia,2002,24(3):201-206.?A
3Singh BN, SignhN. What is the future of agents that specifically reduce heart rate. Medicographia,2002,24(3): 237-244.?A
4Palatini P, JuliusS. Heart rate and the cardiovascular risk. J Hypertens,1997,15(1):3-17.?A
5VilaineJ P, ThollonC, Villeneuve N ,et al. Procoralan, a new selective if current inhibitor. Eur Heart Joumal,2003,5(Suppl G): G26 - G35.?A
6Olshansky B, Rosenfeld LE, Warner AL, et al. The atrial fibrillation follow- up investigation of rhythm management (AFFIRM) study: approaches to control rate in atrial fibrillation. J Am Coll Cardiol,2004,43(7): 1 201 - 1 208.?A
7CIBIS- Investigators and Committees. The cardiac insufficiency bisoprolol study Ⅱ(CIBIS- Ⅱ ):a randomized trial. Lancet, 1999,353(9 146):9-13.?A
8MERIT- HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heartfailure (MERIT- HF).Lancet,1999,353(9 167):2 001-2 007.?A
9Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS)study. Circulation,2002,106(17) :2 194 - 2 199.?A
10Zuanetti G, Mantini I, Hemandez- Bernal F,et al. Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction:insights from the GISSI - 2 study. Eur Heart J, 1998,19(Suppl F): F19-F26.?A
1Destro M,Luckow A,Samson M,et al.Efficacy and safety ofAmlodipineAiralsartan compared with amlodipine monothera-py in patients with stage 2 hypertension:a randomized,dou-ble-blind,multicenter study:the EX-EFFeCTS Study[J].JAm Soc Hypertens,2008,2(4):294-302.
2Rosendorff C,Black HR,Cannon C,et al.Treatment of hy-pertension in the prevention and management of ischemicheart disease:a scientific statement from the American HeartAssociation Council for high blood pressure research and thecouncils on clinical cardiology and epidemiology and preven-tion[J].Circulation,2007,29,115(21):2761-2788.
4Sahinarslan A,Cengel A,Okyay K,et al.B-type natriureticpeptide and extent of lesion on coronary angiography in sta-ble coronary artery disease[J].Coron Artery Dis,2005,16(4):225-229.
